Many Drugs Approved by FDA Based on Results of a Single Study, Analysis Finds

An analysis reveals that many FDA drug approvals from 2016 to 2024 were based on single studies, with industry-sponsored studies on the rise and longer delays in public reporting. This regulatory finding impacts medical device and pharmaceutical decision-making.